Protalix Biotherapeutics Inc (PLX)
Stock-Based Compensation
$398.00K
Quarterly · Period ending: · USD
PLX Stock-Based Compensation
Latest reported$398.00Kperiod ending
Latest reported$398.00Kperiod ending
PLX Quarterly Stock-Based Comp ($0.00 → $398.00K)
Quarterly stock-based compensation
High-resolution chart · PNG
PLX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 398,000 | |
| 532,000 | |
| 732,000 | |
| 598,000 | |
| 427,000 | |
| 540,000 | |
| 654,000 | |
| 620,000 | |
| 998,000 | |
| 981,000 | |
| 1,367,000 | |
| 1,097,000 | |
| 438,000 | |
| 546,000 | |
| 539,000 | |
| 422,000 | |
| 288,000 | |
| 836,000 | |
| 418,000 | |
| 563,000 | |
| 578,000 | |
| 816,000 | |
| 1,014,000 | |
| 1,414,000 | |
| 267,000 | |
| 431,000 | |
| 236,000 | |
| 196,000 | |
| 113,000 | |
| 290,000 | |
| 418,000 | |
| 22,000 | |
| 12,000 | |
| 62,000 | |
| 46,000 | |
| 75,000 | |
| 98,000 | |
| 118,000 | |
| 223,000 | |
| 163,000 | |
| 227,000 | |
| 375,000 | |
| 383,000 | |
| 446,000 | |
| 554,000 | |
| 419,000 | |
| 559,000 | |
| 106,000 | |
| -93,000 | |
| 670,000 | |
| 636,000 | |
| 954,000 | |
| 1,132,000 | |
| 1,367,000 | |
| 1,686,000 | |
| 2,306,000 | |
| 3,630,000 | |
| 129,000 | |
| 156,000 | |
| 209,000 | |
| 279,000 | |
| 242,000 | |
| 395,000 | |
| 355,000 | |
| 248,000 | |
| 284,000 | |
| 681,000 | |
| 838,000 | |
| 702,000 | |
| 462,000 | |
| 3,071,000 | |
| 0 | |
| 0 | |
| 2,174,000 | |
| 10,845,000 | |
| 0 | |
| 0 | |
| 1,451,000 | |
| 3,421,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |